Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of dimethyl fumarate in treatment-naïve Japanese patients with multiple sclerosis: Interim analysis of the randomized placebo-controlled study.
Mori M, Ohashi T, Onizuka Y, Hiramatsu K, Hase M, Yun J, Matta A, Torii S. Mori M, et al. Among authors: hase m. Mult Scler J Exp Transl Clin. 2019 Jun 10;5(2):2055217319852727. doi: 10.1177/2055217319852727. eCollection 2019 Apr-Jun. Mult Scler J Exp Transl Clin. 2019. PMID: 31218077 Free PMC article.
Efficacy of dimethyl fumarate in Japanese multiple sclerosis patients: interim analysis of randomized, double-blind APEX study and its open-label extension.
Kondo T, Kawachi I, Onizuka Y, Hiramatsu K, Hase M, Yun J, Matta A, Torii S. Kondo T, et al. Among authors: hase m. Mult Scler J Exp Transl Clin. 2019 Jul 31;5(3):2055217319864974. doi: 10.1177/2055217319864974. eCollection 2019 Jul-Sep. Mult Scler J Exp Transl Clin. 2019. PMID: 31391949 Free PMC article.
72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension.
Ochi H, Niino M, Onizuka Y, Hiramatsu K, Hase M, Yun J, Matta A, Torii S. Ochi H, et al. Among authors: hase m. Adv Ther. 2018 Oct;35(10):1598-1611. doi: 10.1007/s12325-018-0788-8. Epub 2018 Sep 11. Adv Ther. 2018. PMID: 30206820 Free PMC article. Clinical Trial.
The burden of multiple sclerosis in Japan.
Nohara C, Hase M, Liebert R, Wu N. Nohara C, et al. Among authors: hase m. J Med Econ. 2017 Dec;20(12):1290-1298. doi: 10.1080/13696998.2017.1373653. Epub 2017 Oct 12. J Med Econ. 2017. PMID: 28849983 Free article.
Genetic variants in C5 and poor response to eculizumab.
Nishimura J, Yamamoto M, Hayashi S, Ohyashiki K, Ando K, Brodsky AL, Noji H, Kitamura K, Eto T, Takahashi T, Masuko M, Matsumoto T, Wano Y, Shichishima T, Shibayama H, Hase M, Li L, Johnson K, Lazarowski A, Tamburini P, Inazawa J, Kinoshita T, Kanakura Y. Nishimura J, et al. Among authors: hase m. N Engl J Med. 2014 Feb 13;370(7):632-9. doi: 10.1056/NEJMoa1311084. N Engl J Med. 2014. PMID: 24521109 Free article.
Long-term prognostic significance of gasping in out-of-hospital cardiac arrest patients undergoing extracorporeal cardiopulmonary resuscitation: a post hoc analysis of a multi-center prospective cohort study.
Nara S, Bunya N, Ohnishi H, Sawamoto K, Uemura S, Kokubu N, Hase M, Narimatsu E, Asai Y, Tahara Y, Atsumi T, Nagao K, Morimura N, Sakamoto T; SAVE-J Study Group. Nara S, et al. Among authors: hase m. J Intensive Care. 2023 Oct 6;11(1):43. doi: 10.1186/s40560-023-00692-1. J Intensive Care. 2023. PMID: 37803414 Free PMC article.
262 results